He became very familiar with the cabal ("deep state"), and then the Q-Plan and President Trump launched WWIII from the day POTUS was elected in 2016.  Charlie is extremely well-connected globally. That is an understatement.

He has known the Dragon family for more than 15 years. The Chinese Dragon family, who are not Communist Chinese but are descended from the Himalayan line, are funding much of this entire Global transition.

In an 8-18-20 video, Charlie said “What most people are oblivious to is this whole financial transition from SWIFT to QFS has been funded by the Dragons … When the Dragon bonds were valued 6-weeks ago they were estimated in the multi-quadrillions.”

Charlie has personally inspected 178 warehouses in Vietnam full of unrecorded Gold. He has been inside two DUMBs that were crammed with cash, gold and valuables.  He is part of the team that is moving Gold, Cash and Valuables around the world for the United States Government to back the currencies for the Revaluation and Global Currency reset.

He knew the Pope had been arrested in March 2020 because some of his Security Team were watching him. He knew 650 plane loads of Gold, Cash and Documents were flown out of the Vatican to Fort Knox because all the teams he uses to move money for him, were hired to clear out the Vatican of its stolen treasure.

Charlie has said from Day One that the virus, vaccines, 5G, ANTIFA and BLM riots, were all smokescreens to implement the following: The Revaluation of Currencies / the Global Currency Reset / NESARA / and GESARA.

Aug. 21 2020 - Gene Cosensei (Decoder) with Cirsten W speak to Charlie Ward - Quantum Signature Unhackable System Voting, clearing out underground DUMBS in Europe, Vatican, Victoria, Melbourne, Hague, Australia, South America.

Charlie Ward video, Q&A with Nicholas ‘Hoddesdon’ Veniamin 8-19-20 

Tammy Victor & Craig Abraham (South Africa) talk to Charlie Ward 8-21-20
19:30 Charlie: I feel very excited about it… we were told very clearly that the old financial system, the SWIFT banking system that was controlled by the Federal Reserve and the deep state would be shut down on August 31 of this year…

19:50 There are a lot of telltale reasons already… the Bank of England’s been closed… the Bank of Spain has been closed… they use different reasons… England’s closed due to Covid-19… Spain’s closed down due to ‘technical difficulties’…

34:00 Craig: I was looking today on the Dinar Intel Chronicles, isn’t it? Very informative. I don’t know who or what but I came across it… can you give me background to the webpage… [IDC]… it’s a blog?...

34:18 Charlie: It’s a blog… these guys are very very well connected… I keep a very close eye on them all… I speak to 2 or 3 of them… but they’re a group that are very well informed…They’re just people that are doing proper research… rather than listening to Mainstream Media…These are hardworking guys who are doing proper, genuine, journalistic research so they can produce a clear picture…And it’s a pleasure knowing them… they’re all good lads… there’s 4 or 5 of them I keep an eye on… it’s very good for me to verify the information I’m getting…

MUST WATCH - Aug. 11 2020 - Michael Tellinger and Charlie Freak Join up the Dots with Charlie Ward

There is a special place in hell awaiting those that have been part of the war on Hydroxychloroquine for political reasons.

They have the blood of tens of thousands on their hands.

Together with censorship of medical opinions is one of the greatest scandals in history.

As professor of epidemiology at Yale School of Public Health, I have authored over 300 peer-reviewed publications and currently hold senior positions on the editorial boards of several leading journals.

I am usually accustomed to advocating for positions within the mainstream of medicine, so have been flummoxed to find that, in the midst of a crisis, I am fighting for a treatment that the data fully support but which, for reasons having nothing to do with a correct understanding of the science, has been pushed to the sidelines.

As a result, tens of thousands of patients with COVID-19 are dying unnecessarily. Fortunately, the situation can be reversed easily and quickly.

I am referring, of course, to the medication hydroxychloroquine.

When this inexpensive oral medication is given very early in the course of illness, before the virus has had time to multiply beyond control, it has shown to be highly effective, especially when given in combination with the antibiotics azithromycin or doxycycline and the nutritional supplement zinc.

On May 27, I published an article in the American Journal of Epidemiology (AJE) entitled, "Early Outpatient Treatment of Symptomatic, High-Risk COVID-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis." That article, published in the world's leading epidemiology journal, analyzed five studies, demonstrating clear-cut and significant benefits to treated patients, plus other very large studies that showed the medication safety.

Physicians who have been using these medications in the face of widespread skepticism have been truly heroic. They have done what the science shows is best for their patients, often at great personal risk.

I myself know of two doctors who have saved the lives of hundreds of patients with these medications, but are now fighting state medical boards to save their licenses and reputations. The cases against them are completely without scientific merit.

Since publication of my May 27 article, seven more studies have demonstrated similar benefit. In a lengthy follow-up letter, also published by AJE, I discuss these seven studies and renew my call for the immediate early use of hydroxychloroquine in high-risk patients.

These seven studies include: an additional 400 high-risk patients treated by Dr. Vladimir Zelenko, with zero deaths; four studies totaling almost 500 high-risk patients treated in nursing homes and clinics across the U.S., with no deaths; a controlled trial of more than 700 high-risk patients in Brazil, with significantly reduced risk of hospitalization and two deaths among 334 patients treated with hydroxychloroquine; and another study of 398 matched patients in France, also with significantly reduced hospitalization risk. Since my letter was published, even more doctors have reported to me their completely successful use.

My original article in the AJE is available free online, and I encourage readers—especially physicians, nurses, physician assistants and associates, and respiratory therapists—to search the title and read it. My follow-up letter is linked there to the original paper.

Beyond these studies of individual patients, we have seen what happens in large populations when these drugs are used. These have been "natural experiments." In the northern Brazil state of Pará, COVID-19 deaths were increasing exponentially. On April 6, the public hospital network purchased 75,000 doses of azithromycin and 90,000 doses of hydroxychloroquine. Over the next few weeks, authorities began distributing these medications to infected individuals. Even though new cases continued to occur, on May 22 the death rate started to plummet and is now about one-eighth what it was at the peak.

Why has hydroxychloroquine been disregarded?

First, as all know, the medication has become highly politicized. For many, it is viewed as a marker of political identity, on both sides of the political spectrum. Nobody needs me to remind them that this is not how medicine should proceed. We must judge this medication strictly on the science. When doctors graduate from medical school, they formally promise to make the health and life of the patient their first consideration, without biases of race, religion, nationality, social standing—or political affiliation. Lives must come first.

Second, the drug has not been used properly in many studies. Hydroxychloroquine has shown major success when used early in high-risk people but, as one would expect for an antiviral, much less success when used late in the disease course. Even so, it has demonstrated significant benefit in large hospital studies in Michigan and New York City when started within the first 24 to 48 hours after admission.

In fact, as inexpensive, oral and widely available medications, and a nutritional supplement, the combination of hydroxychloroquine, azithromycin or doxycycline, and zinc are well-suited for early treatment in the outpatient setting. The combination should be prescribed in high-risk patients immediately upon clinical suspicion of COVID-19 disease, without waiting for results of testing. Delays in waiting before starting the medications can reduce their efficacy.

Third, concerns have been raised by the FDA and others about risks of cardiac arrhythmia, especially when hydroxychloroquine is given in combination with azithromycin. The FDA based its comments on data in its FDA Adverse Event Reporting System. This reporting system captured up to a thousand cases of arrhythmias attributed to hydroxychloroquine use. In fact, the number is likely higher than that, since the reporting system, which requires physicians or patients to initiate contact with the FDA, appreciably undercounts drug side effects.

But what the FDA did not announce is that these adverse events were generated from tens of millions of patient uses of hydroxychloroquine for long periods of time, often for the chronic treatment of lupus or rheumatoid arthritis. Even if the true rates of arrhythmia are ten-fold higher than those reported, the harms would be minuscule compared to the mortality occurring right now in inadequately treated high-risk COVID-19 patients.

This fact is proven by an Oxford University study of more than 320,000 older patients taking both hydroxychloroquine and azithromycin, who had arrhythmia excess death rates of less than 9/100,000 users, as I discuss in my May 27 paper cited above. A new paper in the American Journal of Medicine by established cardiologists around the world fully agrees with this.

In the future, I believe this misbegotten episode regarding hydroxychloroquine will be studied by sociologists of medicine as a classic example of how extra-scientific factors overrode clear-cut medical evidence.

But for now, reality demands a clear, scientific eye on the evidence and where it points. For the sake of high-risk patients, for the sake of our parents and grandparents, for the sake of the unemployed, for our economy and for our polity, especially those disproportionally affected, we must start treating immediately.